Acadia Pharma (ACAD) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $22.09 +2.17%
Revenue Growth %: +12.1%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +12.1%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $15.29 million versus the consensus estimate of $15.19 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
